mvabea
janssen-cilag international n.v. - recombinant modified vaccinia ankara bavarian nordic virus encoding the: ebola virus zaire (zebov) mayinga strain glycoprotein (gp); ebola virus sudan gulu strain gp; ebola virus taï forest strain nucleoprotein and the marburg virus musoke strain gp - Αιμορραγικό Πυρετό, Του Έμπολα - Εμβόλια - active immunization for prevention of disease caused by ebola virus (zaire ebolavirus species) in individuals ≥ 1 year of age.
imvanex
bavarian nordic a/s - τροποποιημένη δαμαλίτιδα Αγκυρα - Βαυαριανός σκανδιναβικός (mva-bn) ιός - smallpox vaccine; monkeypox virus - Άλλα ιογενή εμβόλια, - active immunisation against smallpox, monkeypox and disease caused by vaccinia virus in adults (see sections 4. 4 και 5. Η χρήση αυτού του εμβολίου θα πρέπει να γίνεται σύμφωνα με τις επίσημες συστάσεις.
tecovirimat siga
siga technologies netherlands b.v. - tecovirimat - poxviridae infections; cowpox; monkeypox; vaccinia; smallpox - Αντιιικά για συστηματική χρήση - tecovirimat siga is indicated for the treatment of the following viral infections in adults and children with body weight at least 13 kg:- smallpox- monkeypox- cowpoxtecovirimat siga is also indicated to treat complications due to replication of vaccinia virus following vaccination against smallpox in adults and children with body weight at least 13 kg (see sections 4. 4 και 5. tecovirimat siga should be used in accordance with official recommendations.
betadine med.l.soap 7.5%
lavipharm ae ΑΓ.ΜΑΡΙΝΑΣ, 19002 ΠΑΙΑΝΙΑ 6691600 - povidone-iodine - med.l.soap (ΣΑΠΟΥΝΙ ΥΓΡΟ ΦΑΡΜΑΚΕΥΤΙΚΟ) - 7.5% - povidone-iodine 75mg - povidone-iodine
mitomycin accord 20mg/vial powder for solution for injection/infusion
accord healthcare s.l.u (0000009808) moll de barcelona, edifici est s/n, planta 6, barcelona, 08039 - mitomycin - powder for solution for injection/infusion - 20mg/vial - mitomycin (0000050077) 20mg - mitomycin
poliovaccine ssi ενεσιμο διαλυμα σε προγεμισμενη συριγγα
statens serum institut, denmark (0000005700) artillerivej 5,, dk-2300 copenhagen s - poliovirus vaccine; poliovirus vaccine; poliovirus vaccine - ΕΝΕΣΙΜΟ ΔΙΑΛΥΜΑ ΣΕ ΠΡΟΓΕΜΙΣΜΕΝΗ ΣΥΡΙΓΓΑ - 8000034777 poliovirus vaccine 40.000000 du; 8000034777 poliovirus vaccine 8.000000 du; 8000034777 poliovirus vaccine 32.000000 du - poliomyelitis, trivalent, inactivated, whole virus
poliovaccine/ajv inj.so.pfs
aj vaccines a/s, denmark artillerivej 5, dk-2300 copenhagen s +45 7229 7000 - poliovirus vaccine; poliovirus vaccine; poliovirus vaccine - inj.so.pfs (ΕΝΕΣΙΜΟ ΔΙΑΛΥΜΑ ΣΕ ΠΡΟΓΕΜΙΣΜΕΝΗ ΣΥΡΙΓΓΑ) - poliovirus vaccine 40du; poliovirus vaccine 8du; poliovirus vaccine 32du - poliomyelitis, trivalent, inactivated, whole virus
bcg vaccine ajvaccines ps.inj.sus 2-8x10 6 cfu/ml
aj vaccines a/s, denmark artillerivej 5, dk-2300 copenhagen s +45 7229 7000 - mycobacterium bovis (bcg) danish strain 1331 - ps.inj.sus (ΚΟΝΙΣ ΚΑΙ ΔΙΑΛΥΤΗΣ ΓΙΑ ΕΝΕΣΙΜΟ ΕΝΑΙΩΡΗΜΑ) - 2-8x10 6 cfu/ml - mycobacterium bovis (bcg) danish strain 1331 0ml - tuberculosis, live attenuated
prepandemic influenza vaccine (h5n1) (surface antigen, inactivated, adjuvanted) novartis vaccines and diagnostics
novartis vaccines and diagnostics s.r.l. - (αιμοσυγκολλητίνη και νευραμινιδάση) του στελέχους Α / Βιετνάμ / 1194/2004 (h5n1) - influenza, human; immunization; disease outbreaks - Εμβόλια - Ενεργός ανοσοποίηση έναντι του υποτύπου h5n1 του ιού της γρίπης Α. , , this indication is based on immunogenicity data from healthy subjects from the age of 18 years onwards following administration of two doses of the vaccine containing a/vietnam/1194/2004 (h5n1)-like strain. , , prepandemic influenza vaccine (h5n1) novartis vaccines and diagnostic should be used in accordance with official recommendations.
covid-19 vaccine (inactivated, adjuvanted) valneva
valneva austria gmbh - covid-19 vaccine (inactivated, adjuvanted, adsorbed) - covid-19 virus infection - Εμβόλια - covid-19 vaccine (inactivated, adjuvanted) valneva is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 18 to 50 years of age. the use of this vaccine should be in accordance with official recommendations.